通过PPAR信号通路的TSR2加剧高血压的更高表达
Ling-Bing Meng1, Gai-Feng Hu2, Tingting Lv1
1Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Aging
|May 30, 2024
概括
在高血压的高血压.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 心血管研究研究心血管研究
背景情况:
- 高血压是一种复杂的心血管疾病,分子机制不明.
- 研究高血压的遗传和分子基础对于开发有效的治疗方法至关重要.
研究的目的:
- 通过识别关键调节基因和途径,阐明高血压的分子机制.
- 通过实验模型验证已识别的基因和通路在高血压中的作用.
主要方法:
- 基因表达综合 (GEO) 高血压数据集的分析.
- 权重基因共同表达网络分析 (WGCNA) 和基因组丰富分析 (GSEA) 以确定差异表达基因 (DEG) 和枢纽基因.
- 细胞实验,包括西部涂抹,以验证基因功能和途径参与.
主要成果:
- 确定了500个DEG,这些DEG富含了PPAR信号传递和胰岛素信号传递等途径.
- 发现了八个中心枢纽基因,其中LYAR,SDAD1,POLR1D和TSR2在高血压组织中表达变化.
- 在高血压模型中,对TSR2的抑制导致了PPAR信号通路中关键蛋白的下调.
结论:
- TSR2在高血压中表达很高,并显著影响PPAR信号通路.
- TSR2可以作为早期诊断和精确治疗高血压的潜在分子标.
- 这项研究为高血压机制研究提供了宝贵的方向.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
711
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
711
Antihypertensive Drugs: Direct Renin Inhibitors
585
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
585
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
617
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
617
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


